480 related articles for article (PubMed ID: 12382158)
41. Low molecular weight heparin administration in cancer patients with hypercoagulability-related complications and carrying brain metastases: a case series study.
Vitale FV; Rotondo S; Sessa E; Parisi A; Giaimo V; D'Angelo A; Antonelli G; Romeo P; Ferraù F
J Oncol Pharm Pract; 2012 Mar; 18(1):10-6. PubMed ID: 21228085
[TBL] [Abstract][Full Text] [Related]
42. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
Tran H; McRae S; Ginsberg J
Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
[TBL] [Abstract][Full Text] [Related]
43. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
[TBL] [Abstract][Full Text] [Related]
44. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma.
Ginzburg E; Cohn SM; Lopez J; Jackowski J; Brown M; Hameed SM;
Br J Surg; 2003 Nov; 90(11):1338-44. PubMed ID: 14598411
[TBL] [Abstract][Full Text] [Related]
45. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
Daskalopoulos ME; Daskalopoulou SS; Liapis CD
Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
[TBL] [Abstract][Full Text] [Related]
46. Wound infection in the management of hip fractures: a comparison between low-molecular weight heparin and mechanical prophylaxis.
Sanchez-Ballester J; Smith M; Hassan K; Kershaw S; Elsworth CS; Jacobs L
Acta Orthop Belg; 2005 Feb; 71(1):55-9. PubMed ID: 15792208
[TBL] [Abstract][Full Text] [Related]
47. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
DeLoughery TG
Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
[TBL] [Abstract][Full Text] [Related]
48. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
49. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
50. Low-molecular-weight heparin in preventing and treating DVT.
Rydberg EJ; Westfall JM; Nicholas RA
Am Fam Physician; 1999 Mar; 59(6):1607-12. PubMed ID: 10193600
[TBL] [Abstract][Full Text] [Related]
51. Initial treatment of venous thromboembolism.
McRae SJ; Ginsberg JS
Circulation; 2004 Aug; 110(9 Suppl 1):I3-9. PubMed ID: 15339875
[TBL] [Abstract][Full Text] [Related]
52. Deep vein thrombosis and pulmonary embolism in the perioperative patient.
Muntz JE
Am J Manag Care; 2000 Nov; 6(20 Suppl):S1045-52. PubMed ID: 11484304
[TBL] [Abstract][Full Text] [Related]
53. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.
Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT;
Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112
[TBL] [Abstract][Full Text] [Related]
54. [Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Aug; 98(8):447-52. PubMed ID: 12928810
[TBL] [Abstract][Full Text] [Related]
55. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
[TBL] [Abstract][Full Text] [Related]
56. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
[TBL] [Abstract][Full Text] [Related]
57. Thromboembolic prophylaxis in head trauma and multiple-trauma patients.
Latronico N; Berardino M
Minerva Anestesiol; 2008 Oct; 74(10):543-8. PubMed ID: 18475247
[TBL] [Abstract][Full Text] [Related]
58. Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia.
Del Principe MI; Buccisano F; Maurillo L; Venditti D; Cefalo M; Sarlo C; Di Caprio L; Di Veroli A; Nasso D; Ceresoli E; Postorino M; Di Piazza F; Colandrea G; Conti F; Del Poeta G; Amadori S; Venditti A
Thromb Res; 2013 Nov; 132(5):511-4. PubMed ID: 24090605
[TBL] [Abstract][Full Text] [Related]
59. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
[TBL] [Abstract][Full Text] [Related]
60. The effect of postoperative anticoagulation on microvascular thrombosis.
Ashjian P; Chen CM; Pusic A; Disa JJ; Cordeiro PG; Mehrara BJ
Ann Plast Surg; 2007 Jul; 59(1):36-9; discussion 39-40. PubMed ID: 17589257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
